Login
Search
Search
0 Dates
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Resting energy expenditure as a surrogate of muscle mass quantification in patients with heart failure and reduced ejection fraction: a pilot prospective cohort study
Session:
SESSÃO DE POSTERS 25 - ALÉM DA RECUPERAÇÃO - AVANÇANDO AS FRONTEIRAS DA REABILITAÇÃO CARDÍACA
Speaker:
Miguel Sobral Domingues
Congress:
CPC 2025
Topic:
J. Preventive Cardiology
Theme:
28. Risk Factors and Prevention
Subtheme:
28.14 Risk Factors and Prevention - Other
Session Type:
Cartazes
FP Number:
---
Authors:
Miguel Sobral Domingues; Débora Correia; Raquel Alves; Rita Barbosa Sousa; Maria Clarissa Rodrigues; Manuel Pedro; Sara Henriques; Vanessa Santos; Helena Santa-Clara; Gonçalo Cunha
Abstract
<p style="text-align:justify"><span style="font-size:12pt"><span style="background-color:white"><span style="font-family:"Times New Roman",serif"><strong><span style="font-family:"Calibri",sans-serif"><span style="color:#373a40">Introduction</span></span></strong><span style="font-family:"Calibri",sans-serif"><span style="color:#373a40">: Sarcopenia is associated with poorer prognosis in heart failure patients. However, measuring muscle mass in clinical practice remains challenging. Given the significant role of muscle mass in energy expenditure among healthy individuals, we hypothesized that resting energy expenditure (REE) could serve as a surrogate for muscle mass quantification in patients with heart failure and reduced ejection fraction (HFrEF), a hypothesis not previously tested.</span></span></span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="background-color:white"><span style="font-family:"Times New Roman",serif"><strong><span style="font-family:"Calibri",sans-serif"><span style="color:#373a40">Objective</span></span></strong><span style="font-family:"Calibri",sans-serif"><span style="color:#373a40">: To evaluate the relationship between REE and muscle mass quantification in HFrEF patients.</span></span></span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="background-color:white"><span style="font-family:"Times New Roman",serif"><strong><span style="font-family:"Calibri",sans-serif"><span style="color:#373a40">Methods</span></span></strong><span style="font-family:"Calibri",sans-serif"><span style="color:#373a40">: In this prospective cohort study, we recruited consecutive patients with HFrEF. Participants underwent dual-energy X-ray absorptiometry (DEXA) and a 30-minute resting metabolism test (RMT) at the same day. Muscle mass was quantified using DEXA, by subtracting bone mineral composition from the obtained whole-body lean mass and adjusted for body surface area. REE was estimated via indirect calorimetry based on the most stable 10-minute period over a 30-minute assessment. Statistical analysis was conducted using Pearson correlation and linear regression to assess the strength and direction of the relationship between these variables and determine the extent to which REE could predict muscle mass quantification.</span></span></span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="background-color:white"><span style="font-family:"Times New Roman",serif"><strong><span style="font-family:"Calibri",sans-serif"><span style="color:#373a40">Results</span></span></strong><span style="font-family:"Calibri",sans-serif"><span style="color:#373a40">: We recruited 24 patients (79% male, mean age 66; mean LVEF 38±7%). This cohort included patients with ischemic heart disease (n=14), dilated cardiomyopathy (n=5), valvular heart disease (n=4) and burnout hypertrophic cardiomyopathy (n=1). The mean muscle mass adjusted for body surface area was 23.4±2.5 kg/m2, and the mean REE was 1.56±0.35 kcal/min. Notably, there was a considerable disparity in the relationship between muscle mass and REE, with muscle mass ranging from 18.9 to 28.9 kg/m² and REE ranging from 1.07 to 2.23 kcal/min. A significant correlation was observed between REE and muscle mass (Pearson coefficient 0.752, p<0.001). Linear regression demonstrated a strong relationship between these two variables (Muscle mass = 14.67 + 5.7*REE; R² = 0.57) – <em>Figure 1</em>.</span></span></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-size:12.0pt">Conclusion</span></strong><span style="font-size:12.0pt"><span style="color:#373a40">: Resting energy expenditure showed a significant correlation with muscle mass quantification in patients with HFrEF, suggesting it could serve as a viable surrogate. Given the promising results of this pilot study, further validation of these findings in real-world settings is warranted. The next phase of this study will involve integrating a simplified resting metabolism protocol during the resting phase of cardiopulmonary exercise testing (CPET) to assess its applicability in a routine clinical practice scenario.</span></span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site